Facebook Linkedin Mail Twitter Youtube
Facebook Linkedin Mail Twitter Youtube

Tag: ENVI

NeuroVasc announces first patient treated in clinical trial evaluating novel stent...

NeuroVasc Technologies recently announced that the first patient has been treated in its US investigational device exemption (IDE) clinical study, the ENVI randomised controlled...
NeuroNews

Write to us
Editor: Jamie Bell [email protected]
Advertising: Michael Broughton [email protected]


United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Facebook Linkedin Mail Twitter Youtube